Changes in Urine Microalbumin-to-Creatinine Ratio in Children with Sickle Cell Disease over Time

Ibrahim F Shatat1, Suparna Qanungo2, Shannon Hudson2

  • 1Pediatric Nephrology and Hypertension, Sidra Medical and Research Center, Doha, Qatar; College of Nursing, Medical University of South Carolina, Charleston, SC, USA; Weill Cornell Medical College, New York, NY, USA.

Frontiers in Pediatrics
|October 25, 2016
PubMed

Insights

Microalbuminuria (MA) in children with sickle cell disease (SCD) can fluctuate over time. Age and bilirubin levels predict MA increase in transfused patients, highlighting the need for further renal injury research.

Area of Science:

  • Pediatric Nephrology
  • Hematology
  • Sickle Cell Disease Research

Background:

  • Microalbuminuria (MA) affects approximately 20% of children with sickle cell disease (SCD).
  • Limited data exists on the progression of MA in pediatric and young adult SCD populations.
  • MA is recognized as an early indicator of renal injury in this demographic.

Purpose of the Study:

  • To analyze the progression of microalbuminuria in children and young adults with SCD.
  • To determine the rate, direction, magnitude, and predictors of microalbuminuria-to-creatinine (MA/Cr) ratio changes over a 5-year period.
  • To investigate factors influencing MA/Cr fluctuations in pediatric SCD patients.

Main Methods:

  • Retrospective analysis of 5-year electronic medical record (EMR) data.
  • Inclusion of 373 children with SCD and at least two MA/Cr ratio measurements.
  • Utilized multivariate logistic regression to identify predictors of MA/Cr change.

Main Results:

  • Of 45 children with baseline MA, 47% persisted with MA, while 24 new cases developed and 24 normalized during follow-up.
  • Age and bilirubin levels were significant predictors of MA/Cr increase in patients receiving blood transfusions.
  • Initial MA level was not a predictor of subsequent MA/Cr change.

Conclusions:

  • Microalbuminuria levels in children and young adults with SCD can increase or decrease over time.
  • Further research is essential to validate MA as a long-term renal injury marker in SCD.
  • Identifying high-risk individuals for worsening MA is crucial for proactive management.
Abstract

Related Concept Videos

Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
564
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
2.0K
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
322
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
285
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.1K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
293